| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |